Study of Safety and Efficacy of BCD-020 Comparing to MabThera in Patients With Rheumatoid Arthritis
NCT01759030
·
clinicaltrials.gov ↗
PHASE3
Phase
COMPLETED
Status
181
Enrollment
INDUSTRY
Sponsor class
Conditions
Rheumatoid Arthritis
Interventions
DRUG:
Rituximab
Sponsor
Biocad